Minute Insight: Pulsed AF Trial Of Medtronic’s PulseSelect PFA System Completes Enrollment

PULSED AF is a 500-patient pivotal trial of Medtronic’s PulseSelect PFA system for treating both paroxysmal and persistent atrial fibrillation in patients who have not responded to drugs.